Pnd32 - Cost Comparison of Multiple Sclerosis First Line Treatment With Available Interferons Within the Brazilian Public Healthcare System
Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1999
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV